With health care costs rising and obesity-related conditions impacting workplace productivity, employers are increasingly ...
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback